Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results

Rhea-AI Summary

Prestige Consumer Healthcare announced its fiscal 2025 first quarter earnings release will be issued on August 8, 2024, before the market opens.

The company will host a conference call to discuss the results at 8:30 a.m. ET the same day. Participants can join the live Internet webcast via the Investor Relations page on the company's website. Phone participants need to register to receive dial-in details and a unique pin. It is recommended to join the call 10 minutes early. A replay of the conference call will be available for a week on the Investor Relations page.

Positive

• Scheduled release of fiscal 2025 Q1 earnings on August 8, 2024, potentially providing market-moving data.

Negative

• None.

TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.

A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat^® and Summer’s Eve^® women's health products, BC^® and Goody's^® pain relievers, Clear Eyes^® and TheraTears^® eye care products, DenTek^® specialty oral care products, Dramamine^® motion sickness treatments, Fleet^® enemas and glycerin suppositories, Chloraseptic^® and Luden's^® sore throat treatments and drops, Compound W^® wart treatments, Little Remedies^® pediatric over-the-counter products, Boudreaux’s Butt Paste^® diaper rash ointments, Nix^® lice treatment, Debrox^® earwax remover, Gaviscon^® antacid in Canada, and Hydralyte^® rehydration products and the Fess^® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com

FAQ

When will Prestige Consumer Healthcare release its fiscal 2025 first quarter earnings results?

Prestige Consumer Healthcare will release its fiscal 2025 first quarter earnings results on August 8, 2024, before the market opens.

How can I participate in the Prestige Consumer Healthcare fiscal 2025 first quarter earnings conference call?

You can participate in the live Internet webcast of the conference call via the Investor Relations page of the company's website. For phone participation, register to receive dial-in details and a unique pin.

What time is the Prestige Consumer Healthcare fiscal 2025 first quarter earnings conference call?

The conference call will be held at 8:30 a.m. ET on August 8, 2024.

Where can I access the replay of the Prestige Consumer Healthcare fiscal 2025 first quarter earnings conference call?

A replay will be available on the Company's Investor Relations page for approximately one week following the live call.